The Cavalier Daily
Serving the University Community Since 1890

Antidepressants increase suicidal thoughts, FDA says in consumer warning

The FDA issued a warning to 10 antidepressant manufactures last Monday stating that the products may actually increase suicidal thoughts in patients.

Jim Tucker, a doctor at the University Hospital, said the University is still analyzing the data in order to assess the risk.

"It is best to keep in mind that those who are depressed would have [suicidal] thoughts," Tucker said.

He added that, "While used in kids, [antidepressants] have side effects, but not suicidal thoughts."

Since the introduction of antidepressants, suicide rates have actually decreased in the U.S., The New York Times reported.

In addition to treating depression in hopes of preventing suicide, Tucker said antidepressants serve a number of other purposes.

"Antidepressants can be used to treat obsessive compulsive disorder, panic disorder and other anxiety conditions," he said.

The New York Times reported that behind cholestoral and heartburnpills antidepressants are the third biggest selling category of drugs worldwide.

Tucker said the FDA's warning will not discourage him from prescribing antidepressants to his patients.

"We explain to parents and patients our concern about the risks to make them aware and alert to it," he said. "It won't stop me from prescribing [antidepressants]."

-- Compiled by Seth Croft

Local Savings

Puzzles
Hoos Spelling
Latest Video

Latest Podcast

Since the Contemplative Commons opening April 4, the building has hosted events for the University community. Sam Cole, Commons’ Assistant Director of Student Engagement, discusses how the Contemplative Sciences Center is molding itself to meet students’ needs and provide a wide range of opportunities for students to discover contemplative practices that can help them thrive at the University.